Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001553350-17-000602
Filing Date
2017-05-15
Accepted
2017-05-15 17:27:11
Documents
74
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT cnab_10q.htm 10-Q 405441
2 CERTIFICATION cnab_ex31z1.htm EX-31 6325
3 CERTIFICATION cnab_ex31z2.htm EX-31.2 6286
4 CERTIFICATION cnab_ex32z1.htm EX-32 3250
  Complete submission text file 0001553350-17-000602.txt   4168522

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cnab-20170331.xml EX-101.INS 745353
6 XBRL SCHEMA FILE cnab-20170331.xsd EX-101.SCH 63332
7 XBRL CALCULATION FILE cnab-20170331_cal.xml EX-101.CAL 60103
8 XBRL DEFINITION FILE cnab-20170331_def.xml EX-101.DEF 201938
9 XBRL LABEL FILE cnab-20170331_lab.xml EX-101.LAB 433420
10 XBRL PRESENTATION FILE cnab-20170331_pre.xml EX-101.PRE 315727
Mailing Address 1600 BROADWAY SUITE 1600 DENVER CO 80202
Business Address 1600 BROADWAY SUITE 1600 DENVER CO 80202 (407) 432-2547
United Cannabis Corp (Filer) CIK: 0001436161 (see all company filings)

EIN.: 261391338 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54582 | Film No.: 17846045
SIC: 2834 Pharmaceutical Preparations